Infant Hearing LossSymptoms, Doctors, Treatments, Advances & More
Learn About Infant Hearing Loss
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Bassett Medical Center
Elizabeth Redd is an Otolaryngologist practicing medicine in Cooperstown, New York. Dr. Redd is rated as a Distinguished provider by MediFind in the treatment of Infant Hearing Loss. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Infant Hearing Loss, DFNB1, Jones Syndrome, and Meniere Disease.
Pediatric Otolaryngology
Albert Park is a Pediatric Otolaryngologist practicing medicine in Salt Lake City, Utah. Dr. Park is rated as an Elite provider by MediFind in the treatment of Infant Hearing Loss. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Hearing Loss, Infant Hearing Loss, Labyrinthitis, Myringotomy, and Mastoidectomy. Dr. Park is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Park is currently accepting new patients.
An Boudewyns practices practicing medicine in Antwerpen, Belgium. Boudewyns is rated as an Elite expert by MediFind in the treatment of Infant Hearing Loss. They are also highly rated in 12 other conditions, according to our data. Their clinical expertise encompasses Infant Hearing Loss, Laryngomalacia, Hearing Loss, Adenoidectomy, and Endoscopy.
Summary: Newborn hearing screening (NHS) is a standard procedure that often triggers acute anxiety in parents. While Emotional Freedom Technique (EFT) has demonstrated efficacy in reducing psychological distress across various clinical settings, its specific application to parental anxiety during the neonatal screening period remains under-researched. This study addresses this gap by investigating the impa...
Summary: This study is a multicenter, single-arm, open-label Phase I/II clinical trial, which is designed to evaluate the safety, tolerability and efficacy of EHT102 injection in treating congenital hearing loss secondary to biallelic mutations of OTOF (DFNB9).Up to 30 pediatric participants (A maximum of 15 participants will be enrolled in each of the United States and China) will be enrolled and dosed wi...